Cite
HARVARD Citation
Esme, P. et al. (2022). Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real‐life experience. Dermatologic therapy. 35 (11), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Esme, P. et al. (2022). Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real‐life experience. Dermatologic therapy. 35 (11), p. n/a. [Online].